Signalling transduction pathways implicated in Nebivolol-induced NO production in endothelial cells.
Kadi
A
A
CNRS - Groupe Mécanique et Ingénierie Cellulaire et Tissulaire 7563, Faculté de Médecine, Nancy Université-UHP, Vandoeuvre les Nancy, France. Assia.Kadi@medicine.uhp-nancy.fr
Moby
V
V
de Isla
N
N
Lacolley
P
P
Menu
P
P
Stoltz
J F
JF
D000818:Animals; D001578:Benzopyrans / Q000494:pharmacology*; D002118:Calcium / Q000378:metabolism*; D002147:Calmodulin / Q000378:metabolism*; D002478:Cells, Cultured; D042783:Endothelial Cells / Q000187:drug effects / Q000502:physiology*; D004983:Ethanolamines / Q000494:pharmacology*; D006801:Humans; D008955:Models, Cardiovascular; D000068577:Nebivolol; D009569:Nitric Oxide / Q000378:metabolism*; D052250:Nitric Oxide Synthase Type III / Q000378:metabolism*; D015398:Signal Transduction / Q000187:drug effects / Q000502:physiology*; D014665:Vasodilator Agents / Q000494:pharmacology
D001578:Benzopyrans; D002147:Calmodulin; D004983:Ethanolamines; D014665:Vasodilator Agents; D000068577:Nebivolol; D009569:Nitric Oxide; D052250:Nitric Oxide Synthase Type III; D002118:Calcium